Evaluate provides trusted commercial intelligence for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions.
Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action:
EvaluatePharma - the trusted global view of the pharmaceutical market's past, present and future performance with consensus forecasts to 2024, company financials, pipelines, deals and more. @EvaluatePharma
EvaluatePharma Vision - the first single view of the risk and reward of the R&D landscape with consensus forecasts, R&D costs at drug and trial level, success rates, predictive timelines and trial outcomes.
EvaluateMedTech - tracks, benchmarks, and forecasts global performance for the medical device and diagnostic industry with consensus forecasts to 2024, company financials and more.
Evaluate Custom Solutions - improve your strategic decision-making with customised solutions and deep insights that draw on our industry expertise and trusted commercial intelligence.
Vantage - award-winning, thought-provoking news and insights into current and future developments in the industry, underpinned by Evaluate's commercial intelligence.
Explore Evaluate at www.evaluate.com.
Twitter: @Evaluatepharma, @Vantageanalysis
Locations:
Evaluate Global HQ:
11-29 Fashion Street
London E1 6PX, UK
Evaluate Americas
EvaluatePharma USA Inc.
60 State Street, Suite 1910
Boston, MA 02109
Evaluate Asia Pacific
Evaluate Japan KK
Akasaka Garden City 4F
4-15-1 Akasaka, Minato-ku
Tokyo 107-0052, Japan